research by the World Health Organization predicts that the world will witness a 70% spike in the overall
cancer cases, of which 60% of the cases will be attributable to Latin America, Asia, and Africa.
The incremental approvals in monoclonal antibody products across Europe and the U.S. have also
contributed to soaring revenue of the global market. The report by TMR suggests that about five to six
monoclonal antibodies are approved each year in these regions. Out of the 60 monoclonal antibodies
approved in Europe in 2015, 48 have hit the market. Thus, the widening product portfolio that comes in a
broad price range has also played a key role in encouraging the uptake of monoclonal antibody
therapeutics.
High Cost of Production Dissuades Market Growth
Though the market is estimated to have a bright potential, it is likely to be shadowed by a few restraints.
The increasing production of biosimilars that are also used for treating various chronic conditions and
autoimmune diseases are expected to eat into the market share of monoclonal antibody therapeutics
market. Furthermore, the patent cliff of several products is also likely to have a negative impact on the
overall earnings of the global market. The market is also anticipated to face a tough challenge due to the
high cost of monoclonal antibodies as their production is exceptionally time-consuming and demands strict
adherence to rules and regulations.
This review is based on Transparency Market Research’s report, titled “Monoclonal Antibody
Therapeutics Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast,
2016 - 2024.”
To Get Full Detail of The Reports @ http://www.transparencymarketresearch.com/monoclonal-
antibody-therapeutics-market.html
The monoclonal antibody therapeutics market has been segmented as follows:
Monoclonal Antibody Therapeutics Market, by Application
Cancer
Autoimmune diseases
Infection
Hematological diseases
Ophthalmological diseases
Others
Monoclonal Antibody Therapeutics Market, by Source
Human
Humanized
Chimeric
Others
Monoclonal Antibody Therapeutics Market, by End Users
Hospitals
Private Clinics
Research Institute
Monoclonal Antibody Therapeutics Market, by Geography
North America